Dalmia Research and Development Limited

Dalmia Research and Development Limited - healthcare in Coimbatore, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U73200TZ2000PLC009484 Incorporated 14 September 2000 ROC Coimbatore HQ Coimbatore, Tamil Nadu, India
Active Public Limited Company healthcare
Data last updated
Revenue · FY 2021
₹72.6 Lakh
▲ 5% YoY
Net loss · FY 2021
₹53.21 Lakh
Net margin -73.3%
EBITDA · FY 2021
-₹52.75 Lakh
EBITDA margin -72.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
26 yrs
Est. 2000
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered

About Dalmia Research and Development Limited

Data last updated:

Dalmia Research and Development Limited is a public limited company based in Coimbatore, Tamil Nadu, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 14 September 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U73200TZ2000PLC009484. Its GSTIN is 33AABCD8640F1ZX (Tamil Nadu). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Kailash Ram and Ravi Chauhan.

Its last annual general meeting (AGM) was held on 25 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at House No.11/24 Shivaji Colony Thadagam Main Road Edayarpalayam Coimbatore – 641025, Tamil Nadu, India – 641025.

As per the financials filed for FY 2021, the company reported a revenue of ₹72.6 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹53.21 Lakh (net margin -73.3%) and EBITDA of -₹52.75 Lakh (EBITDA margin -72.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 30% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U73200TZ2000PLC009484
Registration Number 009484
Incorporation Date 14 September 2000
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant

Contact details

Dalmia Research and Development Limited's registered office is in Coimbatore, Tamil Nadu. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    House No.11/24 Shivaji Colony Thadagam Main Road Edayarpalayam Coimbatore – 641025, Tamil Nadu, India – 641025
  • Industry
    Healthcare, Ayurvedic Products & Services

To see the full contact details of Dalmia Research and Development Limited, buy the company report.

Comprehensive company report
Dalmia Research and Development Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dalmia Research and Development is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Dalmia Research and Development Limited, buy the company report.

Financials of Dalmia Research and Development Limited

FY 2021 filings available

Dalmia Research and Development Limited reported revenue of ₹72.6 Lakh (up 5% YoY) for FY 2021.

Revenue · FY 2021
₹72.6 Lakh ▲ 5%
Net loss · FY 2021
₹53.21 Lakh margin -73.3%
EBITDA · FY 2021
-₹52.75 Lakh margin -72.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 5%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▼ 58%
5 years · compounded
▼ 281%

Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 5% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹52.75 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹53.21 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-72.7%
Net Profit Margin-73.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dalmia Research and Development Limited, buy the company report.

Board of directors of Dalmia Research and Development Limited

Dalmia Research and Development has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kailash RamAdditional Director04 Oct 20215 Years 0 MonthsCurrent
Ravi ChauhanAdditional Director26 Sep 20197 Years 0 MonthsCurrent
Narender PalAdditional Director04 Jun 20215 Years 4 MonthsCurrent

Shareholding

The shareholding of Dalmia Research and Development Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dalmia Research and Development Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dalmia Research and Development Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Dalmia Research and Development has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
33AABCD8640F1ZXTamil NaduActive16 Jul 2017
09AABCD8640F1ZOUttar PradeshActive07 Sep 2018

To see the full GST registrations and return filing status of Dalmia Research and Development Limited, buy the company report.

Recent activity

Dalmia Research and Development Limited has 14 board changes on record since 2010: 3 appointments and 11 cessations. The latest: Sunita Yadav ceased to be Director on 12 Oct 2021.

AGM
Dalmia Research And Development Limited last Annual general meeting of members was held on 25 Nov 2021 as per latest MCA records.
Ceased
Sunita Yadav ceased to be Director.
Appointed
Kailash Ram was appointed as Additional Director.
Appointed
Narender Pal was appointed as Additional Director.
Filing
Dalmia Research And Development Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Coimbatore.
Ceased
Anurag Sen ceased to be Director.
Appointed
Ravi Chauhan was appointed as Additional Director.
Ceased
Abhishek Dhelia ceased to be Additional Director.
Ceased
Neeraj Kumar Tanwar ceased to be Director.
Ceased
Murali Panchapagesa Muthuswamy ceased to be Director.
Ceased
Sankarasubramanian Lakshmisubramanian ceased to be Director.
Ceased
Sugumaran Periakaruppan ceased to be Additional Director.

5 earlier events are in the company report.

Frequently asked questions

Dalmia Research and Development is an active public limited company based in Coimbatore, Tamil Nadu, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 14 September 2000 (26+ years old) and is registered under CIN U73200TZ2000PLC009484.

Dalmia Research and Development has 3 current directors:

The latest financial statements of Dalmia Research and Development on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 25 November 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Dalmia Research and Development is 33AABCD8640F1ZX, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AABCD8640F1ZO (Uttar Pradesh).

The CIN (Corporate Identification Number) of Dalmia Research and Development is U73200TZ2000PLC009484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dalmia Research and Development was incorporated on 14 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Coimbatore.

Sunita Yadav ceased to be Director on 12 Oct 2021. Kailash Ram was appointed as Additional Director on 04 Oct 2021. Narender Pal was appointed as Additional Director on 04 Jun 2021. Dalmia Research and Development has 14 board changes on record in total.

The registered office of Dalmia Research and Development is at House No.1124 Shivaji Colony Thadagam Main Road Edayarpalayam Coimbatore – 641025, Tamil Nadu, India – 641025.

Dalmia Research and Development operates in the healthcare industry, in the ayurvedic products and services segment.

The compliance status of Dalmia Research and Development is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.